4D Molecular Therapeutics Inc (FDMT) stock news · rev $85.2M
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
This FDMT news page leads with what 4D Molecular Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for FDMT yet. We will not pad this page with generic market recap.
Latest reported FDMT revenue for 2025-12-31 was $85.2M. Net income was -$140.1M. Revenue was up 230194.6% from 2024-12-31 to 2025-12-31. FDMT currently screens at market cap $518.1M.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the FDMT stock page; for the tape open the quote page.
FDMT stock news FAQ
What are FDMT's latest revenue and net income?
Latest cached 4D Molecular Therapeutics Inc (FDMT) revenue for Dec 31, 2025 was $85.2M. Net income was -$140.1M. Statements: https://lician.com/financials/fdmt
How did FDMT revenue change from the prior cached period?
Cached 4D Molecular Therapeutics Inc (FDMT) revenue was up 230194.6% from $37.0K (Dec 31, 2024) to $85.2M (Dec 31, 2025). Statements: https://lician.com/financials/fdmt
What is FDMT's market cap?
4D Molecular Therapeutics Inc (FDMT) market cap is $518.1M on the latest cached fundamentals snapshot.
What kind of company is FDMT?
4D Molecular Therapeutics Inc (FDMT) is a biotechnology company listed on US.
Where is FDMT stock news listed?
Cached stock news for 4D Molecular Therapeutics Inc (FDMT) is listed at https://lician.com/news/fdmt. Filings: https://lician.com/sec/fdmt
Not investment advice.